Literature DB >> 25137385

DNA nanoparticles with core-shell morphology.

Preethi L Chandran1, Emilios K Dimitriadis, Julianna Lisziewicz, Vlad Speransky, Ferenc Horkay.   

Abstract

Mannobiose-modified polyethylenimines (PEI) are used in gene therapy to generate nanoparticles of DNA that can be targeted to the antigen-presenting cells of the immune system. We report that the sugar modification alters the DNA organization within the nanoparticles from homogenous to shell-like packing. The depth-dependent packing of DNA within the nanoparticles was probed using AFM nano-indentation. Unmodified PEI-DNA nanoparticles display linear elastic properties and depth-independent mechanics, characteristic of homogenous materials. Mannobiose-modified nanoparticles, however, showed distinct force regimes that were dependent on indentation depth, with 'buckling'-like response that is reproducible and not due to particle failure. By comparison with theoretical studies of spherical shell mechanics, the structure of mannobiosylated particles was deduced to be a thin shell with wall thickness in the order of few nanometers, and a fluid-filled core. The shell-core structure is also consistent with observations of nanoparticle denting in altered solution conditions, with measurements of nanoparticle water content from AFM images, and with images of DNA distribution in Transmission Electron Microscopy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25137385      PMCID: PMC4348574          DOI: 10.1039/c4sm00908h

Source DB:  PubMed          Journal:  Soft Matter        ISSN: 1744-683X            Impact factor:   3.679


  32 in total

Review 1.  DNA nanoparticles and development of DNA delivery vehicles for gene therapy.

Authors:  Veena Vijayanathan; Thresia Thomas; T J Thomas
Journal:  Biochemistry       Date:  2002-12-03       Impact factor: 3.162

2.  Counterion-induced condesation of deoxyribonucleic acid. a light-scattering study.

Authors:  R W Wilson; V A Bloomfield
Journal:  Biochemistry       Date:  1979-05-29       Impact factor: 3.162

Review 3.  Poly(ethylenimine) and its role in gene delivery.

Authors:  W T Godbey; K K Wu; A G Mikos
Journal:  J Control Release       Date:  1999-08-05       Impact factor: 9.776

Review 4.  Polyethylenimines for in vivo gene delivery.

Authors:  G F Lemkine; B A Demeneix
Journal:  Curr Opin Mol Ther       Date:  2001-04

5.  Overall interaction of cytosolic proteins with the PEI/DNA complex.

Authors:  Takayuki Iida; Takeshi Mori; Yoshiki Katayama; Takuro Niidome
Journal:  J Control Release       Date:  2007-01-09       Impact factor: 9.776

6.  Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybrid.

Authors:  Devaveena Dey; Mohammed Inayathullah; Andrew S Lee; Melburne C LeMieux; Xuexiang Zhang; Yi Wu; Divya Nag; Patricia Eliza De Almeida; Leng Han; Jayakumar Rajadas; Joseph C Wu
Journal:  Biomaterials       Date:  2011-04-08       Impact factor: 12.479

7.  Polyethyleneimine-mediated gene delivery into human adipose derived stem cells.

Authors:  Hyun Hee Ahn; Jung Hwa Lee; Kyung Sook Kim; Ju Young Lee; Moon Suk Kim; Gilson Khang; Il Woo Lee; Hai Bang Lee
Journal:  Biomaterials       Date:  2008-03-04       Impact factor: 12.479

8.  Biophysical characterization of PEI/DNA complexes.

Authors:  Sirirat Choosakoonkriang; Brian A Lobo; Gary S Koe; Janet G Koe; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

Review 9.  Mannose-targeted systems for the delivery of therapeutics.

Authors:  Juan M Irache; Hesham H Salman; Carlos Gamazo; Socorro Espuelas
Journal:  Expert Opin Drug Deliv       Date:  2008-06       Impact factor: 6.648

10.  Condensation of DNA by multivalent cations: considerations on mechanism.

Authors:  V A Bloomfield
Journal:  Biopolymers       Date:  1991-11       Impact factor: 2.505

View more
  1 in total

1.  Unusual Salt and pH Induced Changes in Polyethylenimine Solutions.

Authors:  Kimberly A Curtis; Danielle Miller; Paul Millard; Saswati Basu; Ferenc Horkay; Preethi L Chandran
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.